Nu Skin Enterprises Receives Hold Rating from Canaccord Genuity (NUS)
Nu Skin Enterprises (NYSE:NUS)‘s stock had its “hold” rating reaffirmed by Canaccord Genuity in a research note issued on Thursday, TheFlyOnTheWall.com reports.
Shares of Nu Skin Enterprises (NYSE:NUS) traded down 21.26% during mid-day trading on Thursday, hitting $90.735. The stock had a trading volume of 5,504,041 shares. Nu Skin Enterprises has a one year low of $37.93 and a one year high of $140.50. The stock has a 50-day moving average of $132.8 and a 200-day moving average of $103.6. The company has a market cap of $5.397 billion and a P/E ratio of 23.58.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Tuesday, October 22nd. The company reported $1.80 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.41 by $0.39. The company had revenue of $927.00 million for the quarter, compared to the consensus estimate of $806.19 million. During the same quarter last year, the company posted $0.87 earnings per share. Nu Skin Enterprises’s revenue was up 76.3% compared to the same quarter last year. On average, analysts predict that Nu Skin Enterprises will post $5.84 earnings per share for the current fiscal year.
A number of other analysts have also recently weighed in on NUS. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Nu Skin Enterprises in a research note to investors on Monday. They now have a $150.00 price target on the stock, up previously from $130.00. Four analysts have rated the stock with a hold rating and five have given a buy rating to the company. Nu Skin Enterprises presently has an average rating of “Buy” and a consensus price target of $122.87.
Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.